Levazeo 12.5 Mg Injection 2 Ml
Levazeo 12.5 MG Description
Levazeo 12.5mg Injection 2Ml contains levosulpiride as its active ingredient. Levosulpiride belongs to the group of medicines known as gastric prokinetics (medicines facilitating control of gastric a
cidity). It is also an atypical antipsychotic. Levazeo 12.5mg Injection 2Ml is primarily prescribed to treat functional dyspepsia (constant acidity due to reasons not known), gastro-oesophageal reflux disease (gastric lining irritated by bile acid causing reflux and acidity), stomach ulcers and vomiting due to acidity. Levazeo 12.5mg Injection 2Ml is also used to treat psychiatric disorders like schizophrenia and depression. Levazeo 12.5mg Injection 2Ml contains levosulpiride as its active ingredient. Levazeo 12.5mg Injection 2Ml comes as a liquid in a glass vial. It is given intramuscularly/intravenously by a medical professional like a doctor or nurse in a hospital/clinic under sterile conditions. It may cause side effects like dizziness, fatigue, menstrual irregularities, increased prolactin, weight changes and enlarged breasts in males. Patients are evaluated for symptoms or side effects and then discharged with instructions. Levazeo 12.5mg Injection 2Ml may cause side effects like nausea, dizziness and headache immediately after administration. Dietary changes and exercise are advised lifestyle changes while taking Levazeo 12.5mg Injection 2Ml. Alcohol is prohibited while taking Levazeo 12.5mg Injection 2Ml.
Product Summary
Offer Price | ₹244.07 |
You Save | ₹39.73 (14% on MRP) |
Contains | Levosulpiride(12.5 Mg) |
Uses | Gastro-oesophageal reflux disease, Functional dyspepsia, Acidity, Vomiting, Constipation, Depression |
Side effects | Headache, Dizziness, Menstrual cycle irregularities, Constipation, Weight changes, Sleep problems, Weakness, Tremors, Increased heart rate |
Therapy | ANTI-PSYCHOTICS |
Uses of Levazeo 12.5 MG
- Levazeo 12.5mg Injection 2Ml is used in the treatment of :
- GERD (gastro oesophagal reflux disease) reflux due to irritated gastric lining caused by bile acid
- Irritable bowel syndrome
- Functional dyspepsia (indigestion due to no known reasons)
- Stomach ulcers
- Vomiting due to indigestion
- Schizophrenia
- Depression
Contraindications of Levazeo 12.5 MG
- Levazeo 12.5mg Injection 2Ml cannot be prescribed to/ given with caution in patients of :
- Allergy to levosulpiride
- Chronic constipation
- Bleeding in the gut
- Epileptic fits
- Manic disorder
- Excess prolactin levels
- Heart problems
- Breast cancer
- Brain tumours
- Porphyria (liver disorder)
- History of stroke
- History/ present neuroendocrine tumour
Side effects of Levazeo 12.5 MG
- Levazeo 12.5mg Injection 2Ml may cause side effects like
- Headache
- Dizziness
- Menstrual cycle irregularity
- Constipation
- Gynecomastia
- Galactorrhea (spontaneous milk secretion)
- Weight changes
- Sleep problems
- Weakness and fatigue
- Tremors
- Excessive sweating
- Increased heart rate
- Decreased blood pressure
Precautions and Warnings of Levazeo 12.5 MG
Pregnancy
Breast Feeding
Driving
Alcohol
Other General Warnings
- You develop an allergy to Levazeo 12.5mg Injection 2Ml.
- You do not wish to take Levazeo 12.5mg Injection 2Ml.
- You develop any other medical issues after taking Levazeo 12.5mg Injection 2Ml.
Mode of Action of Levazeo 12.5 MG
How Does It Work?
Directions for Use of Levazeo 12.5 MG
- Take Levazeo 12.5mg Injection 2Ml intramuscularly/intravenously by a doctor or a medical professional in a clinic/hospital setting under sterile conditions.
- Inspect the vial is a must before administering for particulate matter or any discolouration.
- Repeat administration if advised by your physician depending on your condition for complete relief from symptoms.
- Dispose of unused liquid in the vial immediately in medical waste.
- Check the expiry date on the label before administering the injection.
- Evaluate the patient for any side effects after administering the injection and discharg with post-care instructions.
Interactions of Levazeo 12.5 MG
Interactions with other medicines
- Levazeo 12.5mg Injection 2Ml should not be given along with/given with caution:
- Dose adjustment may also be required in cases of increased or decreased efficacy.
- Benzodiazepines increase the severity of side effects.
- Tramadol (painkiller) causes irregular heartbeat.
- Ipratropium (lung medication) increases depression of the nervous system.
- Sucralfate (gastric ulcers medication) increases the efficacy of Levazeo 12.5mg Injection 2Ml.
- Pregabalin (anticonvulsant) increases respiratory depression.
- Diltiazem (blood pressure medication) can cause irregular heartbeat.
- Amisulpride (anti-emetic) causes respiratory depression and breathing difficulties.
- Amitriptyline (antidepressant) decreases the activity of the central nervous system.
- Caution with all high blood pressure medicines may cause a severe drop in blood pressure when given along with Levazeo 12.5mg Injection 2Ml.
Interactions with food items
- Levazeo 12.5mg Injection 2Ml is not known to interact adversely with any food. A balanced diet should be maintained while taking this medication. Any required dietary changes must be discussed with your physician....
Storage and disposal of Levazeo 12.5 MG
Dosage of Levazeo 12.5 MG
Overdose
Missed a Dose
Content Details
Dr. Divya Rohra
MBBS
Dr. Jagruti Jain
M.B.B.S., M.D., D.N.B., General Medicine
Frequently Asked Questions (FAQs)
Q: Does Levazeo 12.5mg Injection 2Ml increase blood pressure?
Q: Can Levazeo 12.5mg Injection 2Ml make me feel sleepy?
Q: Can I take Levazeo 12.5mg Injection 2Ml by myself at home?
References
- Joe, J. (2020). Levosulpiride-induced neurological adverse effects: A prospective study from a tertiary care center. Annals of Indian Academy of Neurology, 23(2), 174–176. [cited 15 March 2022].
- Song, C. W., Chun, H. J., Kim, C. D., Ryu, H. S., Choe, J. G., & Hyun, J. H. (1998). Effects of levosulpiride in patients with functional dyspepsia accompanied by delayed gastric emptying. The Korean Journal of Internal Medicine, 13(1), 15–21. [cited 15 March 2022].
- (N.d.). Sciencedirect.Com. [cited 15 March 2022].